These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Identification of novel compound heterozygous variants in SLC19A2 and the genotype-phenotype associations in thiamine-responsive megaloblastic anemia. Zhang S; Qiao Y; Wang Z; Zhuang J; Sun Y; Shang X; Li G Clin Chim Acta; 2021 May; 516():157-168. PubMed ID: 33571483 [TBL] [Abstract][Full Text] [Related]
23. The spectrum of mutations, including four novel ones, in the thiamine-responsive megaloblastic anemia gene SLC19A2 of eight families. Raz T; Labay V; Baron D; Szargel R; Anbinder Y; Barrett T; Rabl W; Viana MB; Mandel H; Baruchel A; Cayuela JM; Cohen N Hum Mutat; 2000; 16(1):37-42. PubMed ID: 10874303 [TBL] [Abstract][Full Text] [Related]
24. Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome. Diaz GA; Banikazemi M; Oishi K; Desnick RJ; Gelb BD Nat Genet; 1999 Jul; 22(3):309-12. PubMed ID: 10391223 [TBL] [Abstract][Full Text] [Related]
25. Thiamine responsive megaloblastic anemia with a novel SLC19A2 mutation presenting with myeloid maturational arrest. Dua V; Yadav SP; Kumar V; Khan AA; Puri R; Verma I; Flanagan SE; Ellard S; Sachdeva A Pediatr Blood Cancer; 2013 Jul; 60(7):1242-3. PubMed ID: 23512295 [No Abstract] [Full Text] [Related]
26. A novel mutation in the SLC19A2 gene in a Turkish male with thiamine-responsive megaloblastic anemia syndrome. Odaman-Al I; Gezdirici A; Yıldız M; Ersoy G; Aydoğan G; Şalcıoğlu Z; Tahtakesen TN; Önal H; Küçükemre-Aydın B Turk J Pediatr; 2019; 61(2):257-260. PubMed ID: 31951336 [TBL] [Abstract][Full Text] [Related]
27. A novel mutation in the SLC19A2 gene in a Turkish male with thiamine-responsive megaloblastic anemia syndrome. Odaman-Al I; Gezdirici A; Yıldız M; Ersoy G; Aydoğan G; Şalcıoğlu Z; Tahtakesen TN; Önal H; Küçükemre-Aydın B Turk J Pediatr; 2019; 61(2):257-260. PubMed ID: 31951337 [TBL] [Abstract][Full Text] [Related]
29. Thiamine transporter mutation: an example of monogenic diabetes mellitus. Alzahrani AS; Baitei E; Zou M; Shi Y Eur J Endocrinol; 2006 Dec; 155(6):787-92. PubMed ID: 17132746 [TBL] [Abstract][Full Text] [Related]
30. Thiamine Responsive Megaloblastic Anaemia, Diabetes Mellitus and Sensorineural Hearing Loss in a Child. Khurshid A; Fatimah S; Altaf C; Malik HS; Sajjad Z; Khadim MT J Coll Physicians Surg Pak; 2018 Sep; 28(9):S169-S171. PubMed ID: 30173687 [TBL] [Abstract][Full Text] [Related]
31. Thiamine-responsive megaloblastic anaemia: a cause of syndromic diabetes in childhood. Olsen BS; Hahnemann JM; Schwartz M; Østergaard E Pediatr Diabetes; 2007 Aug; 8(4):239-41. PubMed ID: 17659067 [TBL] [Abstract][Full Text] [Related]
33. Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness. Labay V; Raz T; Baron D; Mandel H; Williams H; Barrett T; Szargel R; McDonald L; Shalata A; Nosaka K; Gregory S; Cohen N Nat Genet; 1999 Jul; 22(3):300-4. PubMed ID: 10391221 [TBL] [Abstract][Full Text] [Related]
34. Whole exome sequencing identifies a new mutation in the SLC19A2 gene leading to thiamine-responsive megaloblastic anemia in an Egyptian family. Amr K; Pawlikowska P; Aoufouchi S; Rosselli F; El-Kamah G Mol Genet Genomic Med; 2019 Jul; 7(7):e00777. PubMed ID: 31144472 [TBL] [Abstract][Full Text] [Related]
35. Recessive SLC19A2 mutations are a cause of neonatal diabetes mellitus in thiamine-responsive megaloblastic anaemia. Shaw-Smith C; Flanagan SE; Patch AM; Grulich-Henn J; Habeb AM; Hussain K; Pomahacova R; Matyka K; Abdullah M; Hattersley AT; Ellard S Pediatr Diabetes; 2012 Jun; 13(4):314-21. PubMed ID: 22369132 [TBL] [Abstract][Full Text] [Related]
36. Diabetic acido-ketosis revealing thiamine-responsive megaloblastic anemia. Bouyahia O; Ouderni M; Ben Mansour F; Matoussi N; Khaldi F Ann Endocrinol (Paris); 2009 Dec; 70(6):477-9. PubMed ID: 19922902 [TBL] [Abstract][Full Text] [Related]
37. The Effects of Genetic Mutations and Drugs on the Activity of the Thiamine Transporter, SLC19A2. Enogieru OJ; Koleske ML; Vora B; Ngo H; Yee SW; Chatad D; Sirota M; Giacomini KM AAPS J; 2021 Mar; 23(2):35. PubMed ID: 33649974 [TBL] [Abstract][Full Text] [Related]
39. Whole-Exome Sequencing Revealed a Pathogenic Nonsense Variant in the SLC19A2 Gene in an Iranian Family with Thiamine-Responsive Megaloblastic Anemia. Mohsen-Pour N; Naderi N; Ghasemi S; Hesami M; Maleki M; Kalayinia S Lab Med; 2022 Nov; 53(6):640-650. PubMed ID: 35686496 [TBL] [Abstract][Full Text] [Related]
40. Thiamine-responsive megaloblastic anemia syndrome. Bay A; Keskin M; Hizli S; Uygun H; Dai A; Gumruk F Int J Hematol; 2010 Oct; 92(3):524-6. PubMed ID: 20835854 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]